Group One Trading’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Group One Trading’s Portfolio MLNT Stock Details MLNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-158,400	Closed	-$84K	–	6125
2019 Q4	$84K	Buy	158,400 +148,200	+1,453%	+$359K	﹤0.01%	3753
2019 Q3	$39K	Sell	10,200 -155,500	-94%	-$560K	﹤0.01%	4104
2019 Q2	$1.1M	Buy	165,700 +161,800	+4,149%	+$616K	0.01%	1522
2019 Q1	$14K	Buy	3,900 +3,300	+550%	+$17.9K	﹤0.01%	4174
2018 Q4	$2K	Sell	600 -6,720	-92%	-$85.9K	﹤0.01%	4693
2018 Q3	$145K	Sell	7,320 -5,560	-43%	-$141K	﹤0.01%	3253
2018 Q2	$409K	Buy	12,880 +10,840	+531%	+$390K	﹤0.01%	2463
2018 Q1	$75K	Sell	2,040 -2,320	-53%	-$153K	﹤0.01%	3436
2017 Q4	$344K	Buy	+4,360	New	+$323K	﹤0.01%	2556

Group One Trading's MLNT Position: Q1 2020 in Review

Group One Trading sold out of Melinta Therapeutics, Inc. Common Stock (MLNT) in Q1 2020, closing a stake of 33,406 shares — an estimated $18K sold.

Group One Trading first reported a position in MLNT in Q2 2018 and held it in 6 quarters. The position peaked at $166K in Q3 2019. 2 funds tracked by Wall St. Rank hold MLNT as of Q1 2020.

Group One Trading reported no remaining Melinta Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
Group One Trading sold 33,406 Melinta Therapeutics, Inc. Common Stock shares in Q1 2020, an estimated $18K.
Group One Trading first reported a position in Melinta Therapeutics, Inc. Common Stock in Q2 2018 and held it in 6 quarters.
Group One Trading's Melinta Therapeutics, Inc. Common Stock position peaked at $166K in Q3 2019.
2 funds tracked by Wall St. Rank held Melinta Therapeutics, Inc. Common Stock as of Q1 2020.

Based on Group One Trading's 13F filing for Q1 2020, filed 13 May 2020.